2021
DOI: 10.1016/j.carbpol.2020.117498
|View full text |Cite
|
Sign up to set email alerts
|

Boosting the antibacterial activity of chitosan–gold nanoparticles against antibiotic–resistant bacteria by Punicagranatum L. extract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 43 publications
(24 citation statements)
references
References 48 publications
0
23
0
Order By: Relevance
“…It was earlier reported that chitosan and its derivatives possess antimicrobial properties against fungi [27][28][29][30][31], bacteria [32][33][34], and viruses [35][36][37][38]. However, the mechanism of their antimicrobial activity has not yet been fully explained.…”
Section: Discussionmentioning
confidence: 99%
“…It was earlier reported that chitosan and its derivatives possess antimicrobial properties against fungi [27][28][29][30][31], bacteria [32][33][34], and viruses [35][36][37][38]. However, the mechanism of their antimicrobial activity has not yet been fully explained.…”
Section: Discussionmentioning
confidence: 99%
“… 86 A research study revealed that chitosan–gold hybrid nanoparticles (CS–AuNPs) presented a synergetic affect against methicillin–resistant S. aureus . 87 Hydrothermal synthesis of pseudo-nanocubes and hematite porous nanorods and their usage in antibacterial applications and visible-light driven photocatalysis were described. In this work, nanostructures were decorated equally with gold nanoparticles to improve their optical activity in visible-light illumination.…”
Section: Gold Nanoparticlesmentioning
confidence: 99%
“…In the biomedical field, recent studies (between 2020 and 2021) mostly exploit CS and plant extracts forming nanocomposites, directed at infection prevention or control, additionally acting against oxidative stress and inflammation overload, which are critical for instance in immunocompromised patients [ 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 ]. CS is a marine-derived cationic polysaccharide, approved by the FDA (Food and Drug Administration) for wound dressing applications and cartilage repairing formulations.…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%